Literature DB >> 33651853

House dust mite sensitization drives cross-reactive immune responses to homologous helminth proteins.

Pedro Henrique Gazzinelli-Guimaraes1, Sasisekhar Bennuru1, Rafael de Queiroz Prado1, Alessandra Ricciardi1, Joshua Sciurba1, Jonah Kupritz1, Matthew Moser1, Olena Kamenyeva2, Thomas B Nutman1.   

Abstract

The establishment of type 2 responses driven by allergic sensitization prior to exposure to helminth parasites has demonstrated how tissue-specific responses can protect against migrating larval stages, but, as a consequence, allow for immune-mediated, parasite/allergy-associated morbidity. In this way, whether helminth cross-reacting allergen-specific antibodies are produced and play a role during the helminth infection, or exacerbate the allergic outcome awaits elucidation. Thus, the main objective of the study was to investigate whether house dust mite (HDM) sensitization triggers allergen-specific antibodies that interact with Ascaris antigens and mediate antibody-dependent deleterious effects on these parasites as well as, to assess the capacity of cross-reactive helminth proteins to trigger allergic inflammation in house dust mite presensitized mice. Here, we show that the sensitization with HDM-extract drives marked IgE and IgG1 antibody responses that cross-react with Ascaris larval antigens. Proteomic analysis of Ascaris larval antigens recognized by these HDM-specific antibodies identified Ascaris tropomyosin and enolase as the 2 major HDM homologues based on high sequence and structural similarity. Moreover, the helminth tropomyosin could drive Type-2 associated pulmonary inflammation similar to HDM following HDM tropomyosin sensitization. The HDM-triggered IgE cross-reactive antibodies were found to be functional as they mediated immediate hypersensitivity responses in skin testing. Finally, we demonstrated that HDM sensitization in either B cells or FcγRIII alpha-chain deficient mice indicated that the allergen driven cell-mediated larval killing is not antibody-dependent. Taken together, our data suggest that aeroallergen sensitization drives helminth reactive antibodies through molecular and structural similarity between HDM and Ascaris antigens suggesting that cross-reactive immune responses help drive allergic inflammation.

Entities:  

Year:  2021        PMID: 33651853      PMCID: PMC7924806          DOI: 10.1371/journal.ppat.1009337

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


  63 in total

1.  Structural and immunologic cross-reactivity among filarial and mite tropomyosin: implications for the hygiene hypothesis.

Authors:  Helton C Santiago; Sasisekhar Bennuru; Alexis Boyd; Mark Eberhard; Thomas B Nutman
Journal:  J Allergy Clin Immunol       Date:  2010-12-24       Impact factor: 10.793

2.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

3.  The prevalence of parasite infestation and house dust mite sensitization in Gabonese schoolchildren.

Authors:  A H van den Biggelaar; C Lopuhaa; R van Ree; J S van der Zee; J Jans; A Hoek; B Migombet; S Borrmann; D Luckner; P G Kremsner; M Yazdanbakhsh
Journal:  Int Arch Allergy Immunol       Date:  2001-11       Impact factor: 2.749

Review 4.  The role of helminth infections in protection from atopic disorders.

Authors:  Maria Yazdanbakhsh; Sitti Wahyuni
Journal:  Curr Opin Allergy Clin Immunol       Date:  2005-10

5.  Ascaris suum enolase is a potential vaccine candidate against ascariasis.

Authors:  Ning Chen; Zi-Guo Yuan; Min-Jun Xu; Dong-Hui Zhou; Xiu-Xiang Zhang; Yan-Zhong Zhang; Xiao-Wei Wang; Chao Yan; Rui-Qing Lin; Xing-Quan Zhu
Journal:  Vaccine       Date:  2012-03-27       Impact factor: 3.641

Review 6.  IgE cross-reactivity between Ascaris lumbricoides and mite allergens: possible influences on allergic sensitization and asthma.

Authors:  N Acevedo; L Caraballo
Journal:  Parasite Immunol       Date:  2011-06       Impact factor: 2.280

Review 7.  Allergenic tropomyosins and their cross-reactivities.

Authors:  Kyoung Yong Jeong; Chein-Soo Hong; Tai-Soon Yong
Journal:  Protein Pept Lett       Date:  2006       Impact factor: 1.890

8.  Cross-reactive IgE antibody responses to tropomyosins from Ascaris lumbricoides and cockroach.

Authors:  Ana Beatriz R Santos; Gutemberg M Rocha; Constance Oliver; Virgínia P L Ferriani; Rodrigo C Lima; Mário S Palma; Valéria S F Sales; Rob C Aalberse; Martin D Chapman; L Karla Arruda
Journal:  J Allergy Clin Immunol       Date:  2008-02-13       Impact factor: 10.793

Review 9.  Chronic helminth infections modulate allergen-specific immune responses: Protection against development of allergic disorders?

Authors:  Hermelijn H Smits; Maria Yazdanbakhsh
Journal:  Ann Med       Date:  2007-06-13       Impact factor: 4.709

10.  Stable isotopic labeling by amino acids in cultured primary neurons: application to brain-derived neurotrophic factor-dependent phosphotyrosine-associated signaling.

Authors:  Daniel S Spellman; Katrin Deinhardt; Costel C Darie; Moses V Chao; Thomas A Neubert
Journal:  Mol Cell Proteomics       Date:  2008-02-06       Impact factor: 5.911

View more
  3 in total

Review 1.  Context-dependent roles of B cells during intestinal helminth infection.

Authors:  Aidil Zaini; Kim L Good-Jacobson; Colby Zaph
Journal:  PLoS Negl Trop Dis       Date:  2021-05-13

2.  Transient Ascaris suum larval migration induces intractable chronic pulmonary disease and anemia in mice.

Authors:  Yifan Wu; Evan Li; Morgan Knight; Grace Adeniyi-Ipadeola; Li-Zhen Song; Alan R Burns; Ana Clara Gazzinelli-Guimaraes; Ricardo Fujiwara; Maria Elena Bottazzi; Jill E Weatherhead
Journal:  PLoS Negl Trop Dis       Date:  2021-12-16

3.  Risk Factors Associated With Health Care Utilization in Preschool Recurrent Wheezers in a Tropical Environment.

Authors:  César Muñoz; Lissette Guevara; María-Isabel Escamilla; Ronald Regino; Nathalie Acevedo; Jose Miguel Escamilla-Arrieta
Journal:  Front Allergy       Date:  2021-10-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.